CCND1 Amplification Contributes to Immunosuppression and Is Associated With a Poor Prognosis to Immune Checkpoint Inhibitors in Solid Tumors

Cyclin D1 (CCND1) amplification relevant to malignant biological behavior exists in solid tumors. The prevalence and utility of CCND1 amplification as a biomarker for the clinical response to treatment with immune checkpoint inhibitors (ICIs) are unknown. Our study is a preliminary investigation mai...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Immunol
Autors principals: Chen, Yu, Huang, Yingying, Gao, Xuan, Li, Yi, Lin, Jing, Chen, Lizhu, Chang, Lianpeng, Chen, Gang, Guan, Yanfang, Pan, Leong Kin, Xia, Xuefeng, Guo, Zengqing, Pan, Jianji, Xu, Yaping, Yi, Xin, Chen, Chuanben
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7438829/
https://ncbi.nlm.nih.gov/pubmed/32903763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01620
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars